Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis
Azafaros, a company aiming to become a leader in lysosomal storage disorders (LSDs), focused on addressing especially neurological symptoms, today announced the publication of proof-of-concept ...
Pharmaceutical Technology on MSN
FDA accepts Beren Therapeutics’ NDA for Niemann-Pick disease
The submission includes data indicating a meaningful survival benefit for infantile-onset NPC patients treated with adrabetadex.
Charlottetown bodybuilder Tommy LeClair hopes to inspire other men over 60 and win gold at his first international competition. The 65-year-old has been training for the past three years for the 2026 ...
We have added more events this year to continue our goal of educating the community on the importance of preserving our water ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results